🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us TONIGHT at 7:00 pm ET for a live discussion where mental health professionals will help you recognize the signs of #PTSD and learn practical ways to #support your loved one’s . YouTube: youtube.com/watch?v=gMakLY… Facebook: facebook.com/events/2548589…

From D.C. to Deerfield – our commitment to the #migraine community continues! We planted nearly 1.8K flags at Lundbeck US, shining a light on those impacted by migraine disease this #MHAM2025. AHDA/THA

What’s one of the hardest parts of dementia caregiving?  According to Nancy Treaster of The Caregiver’s Journey podcast, it's agitation — those moments of restlessness, confusion, or distress that can feel overwhelming for both the person with dementia and their caregiver. 😵‍💫

Team Lundbeck kept its purple tutu and spirit tradition going strong at this year's @Miles4Migraine Chicago event. We're proud to stand with the migraine community, championing a path to better days for people living with migraine. #MHAM2025 #Migraine #MigraineAwareness

We’re honored to be named one of FORTUNE's Best Workplaces in Chicago for the second consecutive year, a great recognition of our people-first culture and colleagues who embody what makes working at Lundbeck US truly special! #BestWorkplaces

Attending #AHSAM? Join Lundbeck’s symposium highlighting first-of-its-kind interictal research and implications for clinical practice with Drs. AmaalStarlingMD and Stewart Tepper on Thursday, June 19. #BrainHealth

Attending #AHSAM? Join Lundbeck tomorrow for a session on first-of-its-kind interictal research and implications for clinical practice, 12:30-1:15 pm, lower level L100 C-H. #BrainHealth

Find us at booth #201 at the American Headache Society Annual Meeting to learn more about our preventive #migraine data and to raise the bar in migraine care: bit.ly/3SWLgmu. #AHSAM #NeuroTwitter

Today in the US, we recognize #Juneteenth — a day that marks a significant moment in American history. At Lundbeck US, we pause to honor the meaning of this day and reflect on its lasting importance for all Americans.

This #ShadesForMigraine Day, we’re standing with the #migraine community to spread a powerful message of advocacy: living with migraine disease should not be minimized. We’re here to help make migraine disease known and give people the visibility they deserve. @shadesformigraine

NEWS: Today, we announced the US FDA has granted orphan drug designation to our investigational drug for the treatment of congenital adrenal hyperplasia (CAH), a rare autosomal recessive disease. Learn more: bit.ly/3HXofxx.

As part of PhRMA's annual Capitol Hill Researcher Fly-in, Lundbeck's Jake Wiener recently joined fellow researchers in Washington, D.C. to meet with members of Congress and inform policymakers on Lundbeck's commitment to developing treatments for conditions with unmet needs.

#DYK that #migraine is a progressive disease? Today, we #RallyAgainstChronicMigraine because it’s time to disrupt the status quo in migraine care. #MHAM2025 #ChronicMigraine #CMADAY2025

Join us on Sept. 22 for an afternoon of #science, #networking, and #collaboration as we explore partnering opportunities to drive neuroscience #innovation forward at our External Innovation Event with MassBio in Cambridge. Learn more and register: bit.ly/44jBrWh.

Our 2025 Golden Ticket in #partnership with LabCentral is now open! We’re inviting early-stage, Boston-based #biotech #innovators to apply for a unique opportunity to accelerate #therapeutic development in neuro-rare diseases: bit.ly/40FUw2r.

#Givingback is core to who we are. Through our paid Volunteer Time Off (VTO) benefit, employees are empowered to make meaningful contributions to our communities. Most recently, our team spent time at Feed My Starving Children, packing meals to #support children experiencing hunger globally.

We were honored to join our global Lundbeck colleagues and the patient advocacy community in Copenhagen for the annual #1VoiceSummit! Nearly 30 advocacy groups, including DBSA and Association of Migraine Disorders®, united to advance #brainhealth and discuss advancements in #neuroscience.

The #AAIC2025 countdown is on. Explore agitation associated with dementia due to Alzheimer’s disease at Lundbeck’s co-sponsored symposium on July 30.

July is #DisabilityPrideMonth—a time to celebrate the strength and resilience of individuals living with disabilities. At Lundbeck US, our mission to advance #brainhealth and transform lives is deeply rooted in a belief that everyone deserves to thrive.

At #AAIC2025, we’re working to advance brain health through science and meaningful change. Join us at booth #720 and at our co-sponsored, data-driven symposium on agitation associated with dementia due to Alzheimer’s disease.